Abstract
Coronary heart disease, especially when it affects younger individuals, tends to cluster in families. Known risk factors occur in 50-75% of patients with myocardial infarction. Yet commonly occurring risk factors are not strongly inherited, and the familial aggregation of coronary heart diseas may not be attributable to familial resemblance in serum cholesterol and blood pressure levels. Alternatively, such aggregation may be due to unknown familial risk factors. Nevertheless, screening of relatives of individuals with evident risk factors is of importance, and environmental manipulation is likely to be of value in prevention of coronary heart disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carlson L. A., Ericsson M. Quantitative and qualitative serum lipoprotein analysis. Part 2. Studies in male survivors of myocardial infarction. Atherosclerosis. 1975 May-Jun;21(3):435–450. doi: 10.1016/0021-9150(75)90055-6. [DOI] [PubMed] [Google Scholar]
- Carlson L. A., Wahlberg F. Serum lipids, intravenous glucose tolerance and their interrelation studied in ischaemic cardiovascular disease. Acta Med Scand. 1966 Sep;180(3):307–315. doi: 10.1111/j.0954-6820.1966.tb02840.x. [DOI] [PubMed] [Google Scholar]
- Deutscher S., Ostrander L. D., Epstein F. H. Familial factors in premature coronary heart disease--a preliminary report from the Tecumseh Community Health Study. Am J Epidemiol. 1970 Mar;91(3):233–237. doi: 10.1093/oxfordjournals.aje.a121133. [DOI] [PubMed] [Google Scholar]
- Epstein F. H. Risk factors in coronary heart disease--environmental and hereditary influences. Isr J Med Sci. 1967 Jul-Aug;3(4):594–607. [PubMed] [Google Scholar]
- Goldstein J. L., Hazzard W. R., Schrott H. G., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 1973 Jul;52(7):1533–1543. doi: 10.1172/JCI107331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldstein J. L., Schrott H. G., Hazzard W. R., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973 Jul;52(7):1544–1568. doi: 10.1172/JCI107332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lewis B., Chait A., Oakley C. M., Wootton I. D., Krikler D. M., Onitiri A., Sigurdsson G., February A. Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J. 1974 Aug 24;3(5929):489–493. doi: 10.1136/bmj.3.5929.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nikkilä E. A., Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet. 1973 May 5;1(7810):954–959. doi: 10.1016/s0140-6736(73)91598-5. [DOI] [PubMed] [Google Scholar]
- Patterson D., Slack J. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet. 1972 Feb 19;1(7747):393–399. doi: 10.1016/s0140-6736(72)90853-7. [DOI] [PubMed] [Google Scholar]
- Stone N. J., Levy R. I., Fredrickson D. S., Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation. 1974 Mar;49(3):476–488. doi: 10.1161/01.cir.49.3.476. [DOI] [PubMed] [Google Scholar]